Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S M Hays

Showing results (11-20 of 37) with videos related to

Pageof 4
Sort By:
Chemosphere|March 1, 1997
The relative susceptibility of animals and humans to the carcinogenic hazard posed by exposure to 2,3,7,8-TCDD: an analysis using standard and internal measures of doseS M Hays, L L Aylward, N J Karch, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|March 15, 2001
A physiologically based model for the ingestion of chromium(III) and chromium(VI) by humansE J O'Flaherty, B D Kerger, S M Hays, et al.
Journal of Toxicology and Environmental Health. Part A|October 16, 2007
Age-specific reference ranges for polychlorinated biphenyls (PCB) based on the NHANES 2001-2002 surveyB R Nichols, K L Hentz, L Aylward, et al.
Risk Analysis : an Official Publication of the Society for Risk Analysis|May 5, 2000
Improving cancer dose-response characterization by using physiologically based pharmacokinetic modeling: an analysis of pooled data for acrylonitrile-induced brain tumors to assess cancer potency in the ratC R Kirman, S M Hays, G L Kedderis, et al.
Regulatory Toxicology and Pharmacology : RTP|October 13, 2006
Biomonitoring equivalents: a screening approach for interpreting biomonitoring results from a public health risk perspectiveS M Hays, R A Becker, H W Leung, et al.
Regulatory Toxicology and Pharmacology : RTP|April 12, 2015
Biomonitoring Equivalents for interpretation of urinary fluorideL L Aylward, S M Hays, A Vezina, et al.
Journal of Toxicology and Environmental Health|December 6, 1996
Observation of steady state in blood and urine following human ingestion of hexavalent chromium in drinking waterD J Paustenbach, S M Hays, B A Brien, et al.
Regulatory Toxicology and Pharmacology : RTP|August 4, 2022
Use of biomarker data and metabolite relative potencies to support derivation of noncancer reference values based on the reproductive and developmental toxicity effects of 1,3-butadieneC R Kirman, C M North, N Y Tretyakova, et al.
Regulatory Toxicology and Pharmacology : RTP|April 9, 2025
Human health risk assessment for exposures to 1,3-butadiene in the United States with input from an independent science advisory panelC R Kirman, G Boysen, M J DiNovi, et al.
Regulatory Toxicology and Pharmacology : RTP|September 27, 2025
Expert panel evaluation of the tumor modes of action for 1,4-dioxane and their implications for human risk assessmentC R Kirman, J S Bus, S Gupta, et al.
Pageof 4

Showing results (11-20 of 37) with videos related to

Sort By:
Pageof 4
Chemosphere|March 1, 1997
The relative susceptibility of animals and humans to the carcinogenic hazard posed by exposure to 2,3,7,8-TCDD: an analysis using standard and internal measures of doseS M Hays, L L Aylward, N J Karch, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|March 15, 2001
A physiologically based model for the ingestion of chromium(III) and chromium(VI) by humansE J O'Flaherty, B D Kerger, S M Hays, et al.
Journal of Toxicology and Environmental Health. Part A|October 16, 2007
Age-specific reference ranges for polychlorinated biphenyls (PCB) based on the NHANES 2001-2002 surveyB R Nichols, K L Hentz, L Aylward, et al.
Risk Analysis : an Official Publication of the Society for Risk Analysis|May 5, 2000
Improving cancer dose-response characterization by using physiologically based pharmacokinetic modeling: an analysis of pooled data for acrylonitrile-induced brain tumors to assess cancer potency in the ratC R Kirman, S M Hays, G L Kedderis, et al.
Regulatory Toxicology and Pharmacology : RTP|October 13, 2006
Biomonitoring equivalents: a screening approach for interpreting biomonitoring results from a public health risk perspectiveS M Hays, R A Becker, H W Leung, et al.
Regulatory Toxicology and Pharmacology : RTP|April 12, 2015
Biomonitoring Equivalents for interpretation of urinary fluorideL L Aylward, S M Hays, A Vezina, et al.
Journal of Toxicology and Environmental Health|December 6, 1996
Observation of steady state in blood and urine following human ingestion of hexavalent chromium in drinking waterD J Paustenbach, S M Hays, B A Brien, et al.
Regulatory Toxicology and Pharmacology : RTP|August 4, 2022
Use of biomarker data and metabolite relative potencies to support derivation of noncancer reference values based on the reproductive and developmental toxicity effects of 1,3-butadieneC R Kirman, C M North, N Y Tretyakova, et al.
Regulatory Toxicology and Pharmacology : RTP|April 9, 2025
Human health risk assessment for exposures to 1,3-butadiene in the United States with input from an independent science advisory panelC R Kirman, G Boysen, M J DiNovi, et al.
Regulatory Toxicology and Pharmacology : RTP|September 27, 2025
Expert panel evaluation of the tumor modes of action for 1,4-dioxane and their implications for human risk assessmentC R Kirman, J S Bus, S Gupta, et al.
Pageof 4